Understanding How Biomarker Testing Behaves in Real Clinical Practice

Biomarker testing adoption rarely evolves uniformly across markets. Differences in testing workflow, turnaround time, reimbursement status, laboratory capability, and guideline implementation continue to shape how precision medicine is practiced across real clinical settings.

BYTEclt analyzes real-world testing activity to understand how companion diagnostics move through hospitals, laboratories, and treatment pathways — revealing where adoption accelerates, where operational friction remains, and how testing behavior ultimately influences patient access and therapy decisions.